1Shepherd FA.Chemotherapy for non-small cell lung cancer: have we reached a new plateau? Semin Oncol, 1999,26:3～11.
2Rodriguez J, Pawel J,Pluzanska A, et al. A muticenter phase Ⅲ study of docetaxel+cisaplatin and docetaxel+carboplatin vs vinorelbine+cisplatinin chemotherapy negative patients with advance and metastatic non-small cell lung cancer .Proc Am Soc Clin Oncol,2001,20:1252.
3Souquet PJ, Tan EH, Rodrigues Pereira J, et al.a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancerpatients.Ann Oncol,2002,13(12):1853～1861.
4Alberola V,Camps C,Provencia D,et al.Cisaplatin/gemcitabine(CG) vs Cisaplatin/gemcitabine/ Vinorelbine(CGV) vs sequential dobulets of gemcitabine/ Vinorelbine followed by ifosfamide/vinorelbine(GV/IV) in advanced non-small cell cell lung cancer:8results of a spanish lung cancer group phase Ⅲ trial. Proc Am Soc Clin Oncol,2001,20:1229.
5Niho S,Kubota K,Ohmatsu H,et al. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.Cancer Chemother Pharmacol, 2003,52(1): 19～24.
6Feliu J, Martin G, Madronal C, et al. Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer.Cancer Chemother Pharmacol,2003,52(3):247～252.
7Pallis AG,Mavroudis D,Androulakis N,et al. ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.Lung Cancer. 2003,40(3):301～307.
8Yano S, Kanematsu T, Miki T, et al. A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa"(1)).Cancer Sci, 2003,94(5):453～458.
8Ohtsuka T, Nomori H, Horio H, et al. Radiologieal examination for peripheral lung cancers and benign nodules less than 10 mm [J]. Lung Cancer, 2003,42(3) :291-296.
9Vencevicius V, Cicenas S, Miliauskas P. Surgical treatment of lung carcinoma in tuberculosis patients [J]. Medicina (Kaunas), 2004,40(12) : 1170-1174.
10Cicenas S, Vencevicious V. Lung cancer in patients with tuberculosis [J 1. World J Surg Oncol, 2007,5 ( 1 ) : 22-26.
